Dow Jones

39,118.86

-0.12%

Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

Regístrate

ABEO

Abeona Therapeutics (ABEO)

Abeona Therapeutics Inc

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:ABEO

1 2 3 4 5 6 7 8 9 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
17/06/2024	16:17	Edgar (US Regulatory)	Form S-3/A - Registration statement under Securities Act of 1933: [Amend]	NASDAQ:ABEO	Abeona Therapeutics Inc
17/06/2024	15:47	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:ABEO	Abeona Therapeutics Inc
12/06/2024	06:01	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:ABEO	Abeona Therapeutics Inc
07/06/2024	15:33	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ABEO	Abeona Therapeutics Inc
03/06/2024	15:30	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:ABEO	Abeona Therapeutics Inc
03/06/2024	06:30	GlobeNewswire Inc.	Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:ABEO	Abeona Therapeutics Inc
28/05/2024	06:30	GlobeNewswire Inc.	Abeona Therapeutics to Present at the Jefferies Global Healthcare Conference	NASDAQ:ABEO	Abeona Therapeutics Inc
15/05/2024	15:31	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:ABEO	Abeona Therapeutics Inc
15/05/2024	06:35	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:ABEO	Abeona Therapeutics Inc
15/05/2024	06:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ABEO	Abeona Therapeutics Inc
15/05/2024	06:30	GlobeNewswire Inc.	Abeona Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Progress	NASDAQ:ABEO	Abeona Therapeutics Inc
13/05/2024	16:03	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:ABEO	Abeona Therapeutics Inc
03/05/2024	06:30	GlobeNewswire Inc.	Abeona Therapeutics Announces Pricing of $75 Million Underwritten Offering of Common Stock and Pre-Funded Warrants	NASDAQ:ABEO	Abeona Therapeutics Inc
22/04/2024	15:05	GlobeNewswire Inc.	Abeona Therapeutics Provides Regulatory Update on Pz-cel	NASDAQ:ABEO	Abeona Therapeutics Inc
18/03/2024	06:30	GlobeNewswire Inc.	Abeona Therapeutics Reports Full Year 2023 Financial Results and Announces Completion of FDA Inspections	NASDAQ:ABEO	Abeona Therapeutics Inc
01/02/2024	06:30	GlobeNewswire Inc.	Abeona Therapeutics Announces Progress Update on Pz-cel Biologics License Application (BLA)	NASDAQ:ABEO	Abeona Therapeutics Inc
08/01/2024	06:30	GlobeNewswire Inc.	Abeona Therapeutics Announces $50 Million Credit Facility	NASDAQ:ABEO	Abeona Therapeutics Inc
27/11/2023	06:30	GlobeNewswire Inc.	Abeona Therapeutics Announces FDA Accepts and Grants Priority Review for Pz-cel Biologics License Application (BLA)	NASDAQ:ABEO	Abeona Therapeutics Inc
13/11/2023	06:30	GlobeNewswire Inc.	Abeona Therapeutics Reports Third Quarter 2023 Financial Results and Corporate Developments	NASDAQ:ABEO	Abeona Therapeutics Inc
26/09/2023	06:30	GlobeNewswire Inc.	Abeona Therapeutics Submits Biologics License Application to U.S. FDA Seeking Priority Review and Approval of EB-101 for the Treatment of Patients with Recessive Dystrophic Epidermolysis Bullosa	NASDAQ:ABEO	Abeona Therapeutics Inc
12/09/2023	06:30	GlobeNewswire Inc.	Abeona Therapeutics Appoints Madhav Vasanthavada, Ph.D., M.B.A. as Chief Commercial Officer	NASDAQ:ABEO	Abeona Therapeutics Inc
07/09/2023	06:30	GlobeNewswire Inc.	Abeona Therapeutics Announces Participation in Upcoming Investor Conferences	NASDAQ:ABEO	Abeona Therapeutics Inc
30/08/2023	06:30	GlobeNewswire Inc.	Abeona Therapeutics Announces Positive Pre-BLA Meeting with FDA for EB-101 and Plans for BLA Submission	NASDAQ:ABEO	Abeona Therapeutics Inc
08/08/2023	06:30	GlobeNewswire Inc.	Abeona Therapeutics Reports Second Quarter 2023 Financial Results	NASDAQ:ABEO	Abeona Therapeutics Inc
28/07/2023	06:30	GlobeNewswire Inc.	Abeona Therapeutics Announces Submission of Briefing Package for Pre-Biologics License Application (BLA) Meeting with FDA in August 2023	NASDAQ:ABEO	Abeona Therapeutics Inc
19/07/2023	07:30	GlobeNewswire Inc.	Abeona Therapeutics Joins Rare Disease Company Coalition	NASDAQ:ABEO	Abeona Therapeutics Inc
10/07/2023	09:41	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:ABEO	Abeona Therapeutics Inc
07/07/2023	07:30	GlobeNewswire Inc.	Abeona Therapeutics Announces Closing of $25 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules	NASDAQ:ABEO	Abeona Therapeutics Inc
03/07/2023	07:45	GlobeNewswire Inc.	Abeona Therapeutics Announces $25 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules	NASDAQ:ABEO	Abeona Therapeutics Inc
03/07/2023	07:34	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:ABEO	Abeona Therapeutics Inc